publication venue for
- Advances in the treatment of polymyalgia rheumatica and giant cell arteritis.. 20. 2024
- Is cell therapy no better than steroid injection? 2024
- Reply to: TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still out.. 17. 2021
- Reply to: Combining TNF blockade with immune checkpoint inhibitors in patients with cancer.. 17. 2021
- Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease?. 12. 2016
- Autoimmunity: effectiveness of treatments for pregnant women with APS.. 6. 2010
- Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus. 2016
- TNF in the era of immune checkpoint inhibitors: friend or foe? 2021
- Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. 2020
- Insights into rheumatic diseases from next-generation sequencing. 2019
- New perspectives on femoroacetabular impingement syndrome. 2016
- Consequences of metabolic and oxidative modifications of cartilage tissue. 2015
- Repair and tissue engineering techniques for articular cartilage. 2014
- Determining who should be referred for total hip and knee replacements. 2013
- Osteoarthritis of the spine: the facet joints. 2012
- Mediators of the inflammatory response to joint replacement devices. 2011
- Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy. 2024
- Rethinking antiphospholipid syndrome to guide future management and research. 2024
- Genetically transitional disease: conceptual understanding and applicability to rheumatic disease. 2024
- Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. 2022
- Type I interferon in rheumatic diseases. 2018
- Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. 2018
- Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. 2016
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies. 2015